Variant report

Variant	esv3387274
Chromosome Location	chr8:62623635-62624488
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr8:62623289-62623862	K562	blood:	n/a	chr8:62623639-62623655
2	ARID3A	chr8:62623170-62623961	HepG2	liver:	n/a	chr8:62623639-62623655
3	ARID3A	chr8:62624117-62626070	K562	blood:	n/a	n/a
4	ATF3	chr8:62623320-62624096	A549	lung:	n/a	n/a
5	ATF3	chr8:62624416-62626593	A549	lung:	n/a	chr8:62625014-62625022 chr8:62625012-62625023 chr8:62625012-62625023
6	BCL3	chr8:62622937-62626728	A549	lung:	n/a	chr8:62622975-62622984 chr8:62623067-62623076 chr8:62626676-62626685
7	BRCA1	chr8:62622929-62623955	Hela-S3	cervix:	n/a	n/a
8	CEBPB	chr8:62623055-62623906	A549	lung:	n/a	chr8:62623272-62623283
9	CEBPB	chr8:62623083-62623843	K562	blood:	n/a	chr8:62623272-62623283
10	CEBPB	chr8:62622909-62623992	A549	lung:	n/a	chr8:62623272-62623283
11	CEBPB	chr8:62623069-62623859	IMR90	lung:	n/a	chr8:62623272-62623283
12	CEBPB	chr8:62623498-62623796	K562	blood:	n/a	n/a
13	CEBPB	chr8:62623062-62623866	Hela-S3	cervix:	n/a	chr8:62623272-62623283
14	CHD1	chr8:62622622-62623971	GM12878	blood:	n/a	n/a
15	CHD1	chr8:62622453-62628339	IMR90	lung:	n/a	chr8:62627291-62627301 chr8:62627210-62627220 chr8:62626642-62626652 chr8:62627205-62627215 chr8:62628180-62628190
16	CTCF	chr8:62623629-62623838	GM13977	blood:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718 chr8:62623653-62623661
17	CTCF	chr8:62623660-62623810	HPF	lung:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718
18	CTCF	chr8:62623738-62623743	MCF-7	breast:	n/a	n/a
19	CTCF	chr8:62623633-62623854	Gliobla	brain:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718 chr8:62623653-62623661
20	CTCF	chr8:62623620-62623770	Caco-2	colon:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718 chr8:62623653-62623661
21	CTCF	chr8:62623603-62623850	Spleen_OC	spleen:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718 chr8:62623653-62623661
22	CTCF	chr8:62623660-62623810	Caco-2	colon:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718
23	CTCF	chr8:62623640-62623790	GM12865	blood:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718 chr8:62623653-62623661
24	CTCF	chr8:62623620-62623770	WERI-Rb-1	eye:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718 chr8:62623653-62623661
25	CTCF	chr8:62623611-62623772	SK-N-SH_RA	brain:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718 chr8:62623653-62623661
26	CTCF	chr8:62623640-62623790	GM12871	blood:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718 chr8:62623653-62623661
27	CTCF	chr8:62623660-62623810	BJ	skin:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718
28	CTCF	chr8:62623620-62623770	GM12865	blood:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718 chr8:62623653-62623661
29	CTCF	chr8:62623700-62623850	GM12864	blood:	n/a	chr8:62623705-62623721 chr8:62623704-62623722 chr8:62623711-62623718
30	CTCF	chr8:62623660-62623810	GM12870	blood:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718
31	CTCF	chr8:62623680-62623830	AG09309	skin:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718
32	CTCF	chr8:62623442-62623969	GM12878	blood:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718 chr8:62623653-62623661
33	CTCF	chr8:62623636-62623846	GM10248	blood:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718 chr8:62623653-62623661
34	CTCF	chr8:62623680-62623830	HFF	foreskin:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718
35	CTCF	chr8:62623740-62623890	HAc	cerebellar:	n/a	n/a
36	CTCF	chr8:62623660-62623810	BE2_C	brain:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718
37	CTCF	chr8:62623660-62623810	Hela-S3	cervix:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718
38	CTCF	chr8:62623648-62623814	HepG2	liver:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718 chr8:62623653-62623661
39	CTCF	chr8:62623516-62623863	T-47D	breast:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718 chr8:62623653-62623661
40	CTCF	chr8:62623620-62623770	WI-38	lung:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718 chr8:62623653-62623661
41	CTCF	chr8:62623625-62623847	GM12878	blood:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718 chr8:62623653-62623661
42	CTCF	chr8:62623640-62623790	AG09309	skin:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718 chr8:62623653-62623661
43	CTCF	chr8:62623680-62623830	BE2_C	brain:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718
44	CTCF	chr8:62623660-62623810	AG09319	gingival:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718
45	CTCF	chr8:62623680-62623830	HCM	heart:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718
46	CTCF	chr8:62623500-62623650	A549	lung:	n/a	n/a
47	CTCF	chr8:62623699-62623768	GM20000	blood:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718
48	CTCF	chr8:62623640-62623790	HepG2	liver:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718 chr8:62623653-62623661
49	CTCF	chr8:62623680-62623830	HEEpiC	esophagus:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718
50	CTCF	chr8:62623640-62623790	AoAF	blood vessel:	n/a	chr8:62623705-62623721 chr8:62623699-62623720 chr8:62623704-62623722 chr8:62623711-62623718 chr8:62623653-62623661

No.	Distal block	Cell Line	Cell type
1	chr8:62621847..62624556-chr8:62711277..62713553,2	K562	blood:
2	chr8:62565425..62565962-chr8:62623306..62624081,2	MCF-7	breast:
3	chr8:62622252..62623796-chr8:64080473..64083451,2	K562	blood:
4	chr8:62620828..62625218-chr8:62625341..62628340,6	MCF-7	breast:
5	chr8:62618042..62628934-chr8:62666240..62683608,38	K562	blood:
6	chr8:62567262..62573065-chr8:62621554..62624953,7	K562	blood:
7	chr8:62538409..62541040-chr8:62622650..62625118,2	K562	blood:
8	chr8:62623830..62626750-chr8:62657804..62660228,2	K562	blood:
9	chr8:62597423..62607954-chr8:62618870..62628159,21	K562	blood:
10	chr8:62560140..62569925-chr8:62619825..62628019,19	K562	blood:
11	chr8:62608231..62611173-chr8:62624445..62626992,3	K562	blood:
12	chr8:62619459..62621551-chr8:62623294..62626246,2	MCF-7	breast:
13	chr8:62564124..62567084-chr8:62621412..62624391,3	MCF-7	breast:
14	chr8:62612675..62615533-chr8:62623174..62625946,2	MCF-7	breast:
15	chr8:62605925..62608885-chr8:62622452..62624247,2	MCF-7	breast:

Variant related genes	Relation type
MIR4470	TF binding region
ENSG00000264408	chromatin interactions
ENSG00000198363	chromatin interactions
ENSG00000270673	chromatin interactions
ENSG00000185728	chromatin interactions
ENSG00000251127	chromatin interactions

Extended variants
information (count: 32 )
Associated
traits (count: 97 )

Variant overlapped rSNPs/rCNVs (count:32 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs375024861	chr8:62623638-62623639	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
2	rs112194619	chr8:62623639-62623640	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
3	rs71257380	chr8:62623648-62623649	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
4	rs199852728	chr8:62623651-62623652	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
5	rs116326431	chr8:62623706-62623707	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
6	rs188595264	chr8:62623722-62623723	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
7	rs150048386	chr8:62623741-62623742	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
8	rs575858124	chr8:62623819-62623820	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
9	rs10095911	chr8:62623854-62623855	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs145343221	chr8:62623891-62623892	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
11	rs532456274	chr8:62623925-62623926	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
12	rs547328285	chr8:62623960-62623961	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
13	rs550984610	chr8:62623990-62623991	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
14	rs140881683	chr8:62624006-62624007	Enhancers Active TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
15	rs561313367	chr8:62624015-62624016	Enhancers Active TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
16	rs569747881	chr8:62624021-62624022	Enhancers Active TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
17	rs35905204	chr8:62624071-62624072	Enhancers Active TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
18	rs537281858	chr8:62624174-62624175	Enhancers Active TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
19	rs552753314	chr8:62624178-62624179	Enhancers Active TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
20	rs570929521	chr8:62624208-62624209	Enhancers Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
21	rs530107077	chr8:62624214-62624215	Enhancers Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
22	rs535331460	chr8:62624219-62624220	Enhancers Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
23	rs546735193	chr8:62624280-62624281	Enhancers Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
24	rs553352666	chr8:62624330-62624331	Enhancers Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
25	rs386726062	chr8:62624402-62624403	Flanking Active TSS Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
26	rs181306524	chr8:62624404-62624405	Flanking Active TSS Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
27	rs185379345	chr8:62624405-62624406	Flanking Active TSS Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
28	rs147946851	chr8:62624407-62624408	Flanking Active TSS Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
29	rs368835612	chr8:62624409-62624410	Flanking Active TSS Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
30	rs386726063	chr8:62624411-62624412	Flanking Active TSS Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
31	rs199914988	chr8:62624412-62624413	Flanking Active TSS Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
32	rs565092289	chr8:62624485-62624486	Flanking Active TSS Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:97)

Disease	PMID	Source
Cancer	16751803	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Ewing''s sarcoma	21437220	CNVD
Autism	19415332	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Esophageal cancer	21851588	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21245420	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
lymphocytic leukemia	21291569	CNVD
Liver carcinoma	19366792	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Seminomas	18059402	CNVD
Autism	22495311	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Pancreatic cancer	21811587	CNVD
Thyroid cancer	19087340	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	17603634	CNVD
Disorders of sex development	21048976	CNVD
Testicular cancer	18059402	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Breast cancer	17133270	CNVD
Breast cancer	21509527	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Cancer	20164919	CNVD
primary effusion lymphomas	17116491	CNVD
Esophageal cancer	20955586	CNVD
Multiple myeloma	16461302	CNVD
abnormal development	18461090	CNVD
Cancer	20164920	CNVD
Oral cancer	21386901	CNVD
Uveal melanoma	21693616	CNVD
Langer-Giedion syndrome	22283845	CNVD
Cancer	21637783	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	20632083	CNVD
Breast cancer	19602461	CNVD
Cancer	22429812	CNVD
Endometrial cancer	22040021	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oral cancer	19627613	CNVD
Prostate cancer	21088497	CNVD
colon cancer	17210682	CNVD
Breast cancer	21264507	CNVD
Breast cancer	22028636	CNVD
Acute myeloid leukemia	16864856	CNVD
Salivary gland tumor	18059337	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Gastric cancer	17167181	CNVD
Colorectal cancer	19359472	CNVD
Breast cancer	16461572	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	16968546	CNVD
head and neck squamous cell carcinoma	18028549	CNVD
Breast cancer	17001317	CNVD
Ewing''s sarcoma	17952124	CNVD
Urothelial carcinoma	21177765	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	16608533	CNVD
Metanephric adenoma	20802469	CNVD
Hepatocellular carcinoma	18803288	CNVD
Prostate cancer	18632612	CNVD
Glioblastoma multiforme	18628472	CNVD
Ovarian cancer	22174824	CNVD
Prostate cancer	16573809	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Colorectal cancer	16272173	CNVD
Melanoma	22183965	CNVD
Cancer	21949371	CNVD
Non-small cell lung cancer	21829676	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Acute myeloid leukemia	21358987	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Adenocarcinoma	21044232	CNVD
Squamous cell cancer	20885788	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
small cell lung cancer	20016488	CNVD
Sezary syndrome	18413736	CNVD
Colorectal cancer	21645411	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Gastric cancer	22014070	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:171 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:62610000-62624400	Weak transcription	iPS-15b Cell Line	embryonic stem cell
2	chr8:62613000-62624600	Weak transcription	Brain Germinal Matrix	brain
3	chr8:62613000-62626400	Weak transcription	Lung	lung
4	chr8:62613800-62624600	Weak transcription	Left Ventricle	heart
5	chr8:62613800-62624600	Weak transcription	Right Ventricle	heart
6	chr8:62613800-62624600	Weak transcription	Thymus	Thymus
7	chr8:62614000-62624400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
8	chr8:62617600-62624000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
9	chr8:62617800-62624400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
10	chr8:62618400-62624600	Enhancers	Rectal Smooth Muscle	rectum
11	chr8:62618600-62624200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
12	chr8:62619200-62624600	Weak transcription	Fetal Thymus	thymus
13	chr8:62619200-62625000	Enhancers	Fetal Heart	heart
14	chr8:62620000-62624400	Enhancers	Cortex derived primary cultured neurospheres	brain
15	chr8:62620000-62624600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
16	chr8:62620200-62624600	Enhancers	Primary hematopoietic stem cells	blood
17	chr8:62620600-62624200	Enhancers	HSMM	muscle
18	chr8:62620800-62623800	Enhancers	HUVEC	blood vessel
19	chr8:62620800-62624000	Flanking Active TSS	Muscle Satellite Cultured Cells	--
20	chr8:62620800-62624200	Enhancers	Primary hematopoietic stem cells short term culture	blood
21	chr8:62621000-62624200	Enhancers	Liver	Liver
22	chr8:62621200-62624200	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
23	chr8:62621200-62624200	Enhancers	Skeletal Muscle Female	skeletal muscle
24	chr8:62621400-62624200	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
25	chr8:62621600-62624200	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
26	chr8:62621800-62624400	Weak transcription	Fetal Stomach	stomach
27	chr8:62621800-62624600	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
28	chr8:62622000-62624600	Enhancers	Fetal Intestine Small	intestine
29	chr8:62622200-62624600	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
30	chr8:62622200-62624600	Weak transcription	Aorta	Aorta
31	chr8:62622200-62624600	Weak transcription	Ovary	ovary
32	chr8:62622200-62624600	Weak transcription	Psoas Muscle	Psoas
33	chr8:62622200-62626200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
34	chr8:62622200-62626200	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
35	chr8:62622200-62626200	Weak transcription	Pancreas	Pancrea
36	chr8:62622200-62626400	Weak transcription	Gastric	stomach
37	chr8:62622400-62624200	Enhancers	Monocytes-CD14+_RO01746	blood
38	chr8:62622400-62626000	Enhancers	Primary T helper cells fromperipheralblood	blood
39	chr8:62622400-62627800	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
40	chr8:62622600-62625800	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
41	chr8:62622800-62623800	Enhancers	Primary T cells from cord blood	blood
42	chr8:62622800-62623800	Enhancers	Primary T killer naive cells fromperipheralblood	blood
43	chr8:62622800-62624000	Enhancers	Primary T helper cells PMA-I stimulated	--
44	chr8:62622800-62624000	Enhancers	Brain Hippocampus Middle	brain
45	chr8:62622800-62624400	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
46	chr8:62622800-62624400	Enhancers	Fetal Intestine Large	intestine
47	chr8:62622800-62624400	Enhancers	Rectal Mucosa Donor 31	rectum
48	chr8:62622800-62624400	Flanking Active TSS	Osteobl	bone
49	chr8:62622800-62624600	Enhancers	Primary monocytes fromperipheralblood	blood
50	chr8:62622800-62624800	Enhancers	Placenta Amnion	Placenta Amnion

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links